iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.730
+0.060 (3.59%)
At close: Jun 29, 2026, 4:00 PM EDT
1.730
0.00 (0.00%)
After-hours: Jun 29, 2026, 4:04 PM EDT
iBio, Inc. Employees
iBio, Inc. had 20 employees as of June 30, 2025. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
$15,000
Profits / Employee
-$1,380,300
Market Cap
85.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 20 | 4 | 25.00% | 20 | 0 |
| Jun 30, 2024 | 16 | -10 | -38.46% | 16 | 0 |
| Jun 30, 2023 | 26 | -80 | -75.47% | 26 | 0 |
| Jun 30, 2022 | 106 | 31 | 41.33% | 105 | 1 |
| Jun 30, 2021 | 75 | 24 | 47.06% | 49 | 26 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| MindWalk Holdings | 102 |
| Adicet Bio | 102 |
| Cardiff Oncology | 31 |
| Entera Bio | 22 |
| Rallybio | 14 |
| MAIA Biotechnology | 13 |
| Alterity Therapeutics | 9 |
IBIO News
- 21 days ago - iBio initiated with an Outperform at Raymond James - TheFly
- 25 days ago - iBio, Inc. Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 27 days ago - iBio to Participate in Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 27 days ago - iBio doses first participant in IBIO-600 trial - TheFly
- 27 days ago - iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity - GlobeNewsWire
- 6 weeks ago - iBio, Inc. Slides: Corporate presentation - Filings
- 6 weeks ago - iBio reports Q3 EPS (7c), consensus (6c) - TheFly
- 6 weeks ago - iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewsWire